Brighton Jones’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$218K Sell
587
-7
-1% -$2.47K ﹤0.01% 1225
2026
Q2
$213K Buy
+594
New +$182K ﹤0.01% 1225
2025
Q4
– Sell
-2,514
Closed -$660K – 980
2025
Q3
$660K Buy
+2,514
New +$611K 0.02% 531

Other funds holding WST

Brighton Jones's WST Position: Q3 2026 in Review

Brighton Jones reduced its West Pharmaceutical (WST) stake by 1.2% in Q3 2026, selling an estimated $2.47K and leaving 587 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Brighton Jones first reported a position in WST in Q3 2025 and has held it in 3 quarters since. The position peaked at $660K in Q3 2025. 751 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Brighton Jones held 587 shares of West Pharmaceutical worth $218K as of Q3 2026.
  • Brighton Jones sold 7 West Pharmaceutical shares in Q3 2026, an estimated $2.47K.
  • West Pharmaceutical made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1225 holding.
  • Brighton Jones first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Brighton Jones's West Pharmaceutical position peaked at $660K in Q3 2025.
  • 751 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.